KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,077 | -70.1% | 21,699 | -60.1% | 0.00% | -66.7% |
| Q2 2023 | $97,371 | -48.1% | 54,397 | +12.9% | 0.01% | -53.8% |
| Q1 2023 | $187,486 | +247.2% | 48,197 | +299.9% | 0.01% | +160.0% |
| Q2 2022 | $54,000 | -86.2% | 12,053 | -77.4% | 0.01% | -85.3% |
| Q1 2022 | $392,000 | +905.1% | 53,300 | +773.8% | 0.03% | +1033.3% |
| Q4 2021 | $39,000 | +3800.0% | 6,100 | +1880.5% | 0.00% | – |
| Q3 2021 | $1,000 | -96.6% | 308 | -84.9% | 0.00% | -100.0% |
| Q3 2020 | $29,000 | -86.6% | 2,039 | -82.0% | 0.00% | -85.7% |
| Q4 2019 | $216,000 | +200.0% | 11,300 | +167.0% | 0.02% | +320.0% |
| Q3 2018 | $72,000 | +3500.0% | 4,232 | +1497.0% | 0.01% | – |
| Q3 2015 | $2,000 | -96.1% | 265 | -75.9% | 0.00% | -100.0% |
| Q2 2014 | $51,000 | – | 1,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |